GIANT CELL ARTERITIS
Clinical trials for GIANT CELL ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tests best way to stop arthritis drug without relapse
Disease control OngoingThis study looks at 120 adults with giant cell arteritis (a type of blood vessel inflammation) who are stable on tocilizumab. It compares stopping the drug suddenly versus tapering it slowly over time. The goal is to see which approach better prevents the disease from flaring up …
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
Head-to-Head: cheaper drug may match expensive biologic for rare artery disease
Disease control OngoingThis study compares two drugs, methotrexate and tocilizumab, for treating giant cell arteritis, a condition that causes inflammation of large arteries. The goal is to see if the less expensive methotrexate works as well as tocilizumab at preventing relapses while reducing the nee…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated May 26, 2026 06:42 UTC
-
New imaging study aims to end guesswork in PMR diagnosis
Diagnosis OngoingThis study explores whether ultrasound and PET/CT scans can accurately diagnose and monitor polymyalgia rheumatica (PMR), a condition causing muscle pain and inflammation. Researchers will follow 98 adults over 50 suspected of having PMR, using imaging at key points during treatm…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated May 22, 2026 14:03 UTC